arrow
P

Peter A. Ljubenkov

University of California, San Francisco
H指数:24
被引数:1,731

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Evaluation of plasma neurofilament and glial fibrillary acidic protein to predict or detect amyloid related imaging abnormalities

血浆神经丝蛋白和胶质纤维酸性蛋白在预测或检测与淀粉样蛋白相关的影像异常中的应用评估

2026-10-010
OAAI
Large-scale cerebrospinal fluid proteomics identifies molecular signatures of disease progression across Alzheimer's disease and sporadic frontotemporal lobar degeneration

大规模脑脊液蛋白质组学鉴定了阿尔茨海默病和散发性额颞叶萎缩中疾病进展的分子特征

2026-01-110
OAAI
Blood-based Alzheimer's disease biomarkers in a behavioral neurology clinic: Real-world implementation, clinical utility, and diagnostic performance

基于血液的阿尔茨海默病生物标志物在行为神经病学诊所的应用:真实世界实施、临床效用和诊断性能

2025-11-130
OAAI
Author Correction: Large-scale network analysis of the cerebrospinal fluid proteome identifies molecular signatures of frontotemporal lobar degeneration

作者更正: 脑脊液蛋白质组的大规模网络分析确定了额颞叶变性的分子特征

2025-07-070
OAAI
Development and validation of the TabCAT-EXAMINER: A tablet-based executive functioning battery for research and clinical trials

TabCAT-EXAMINER的开发与验证:一种基于平板电脑的用于研究和临床试验的执行功能测试组合

2025-03-010
PRE
Co-pathology may impact outcomes of amyloid-targeting treatments: clinicopathological results from two patients treated with aducanumab( vol 146 , pg 777 , 2023)

共病病理可能影响靶向治疗淀粉样蛋白的治疗结局:来自接受阿杜单抗治疗的两位患者的临床病理结果(卷 146,页 777,2023)

2025-02-130
OA
Clinical and neuropathological associations of plasma Aβ42/Aβ40, p-tau217 and neurofilament light in sporadic frontotemporal dementia spectrum disorders
2025-01-290
OA
CSF Proteomics in Patients With Progressive Supranuclear Palsy
2024-08-130
PRE
Evaluating the Effect of Alzheimer's Disease-Related Biomarker Change in Corticobasal Syndrome and Progressive Supranuclear Palsy

评估阿尔茨海默病相关生物标志物变化对皮质基底节综合征和进行性核上性麻痹的影响

2024-04-058
OA
Clinicopathological correlation of cerebrospinal fluid alpha-synuclein seed amplification assay in a behavioral neurology autopsy cohort

行为神经病学尸检队列中脑脊液 α-突触核蛋白种子扩增试验的临床病理相关性

2024-03-277
OAAI
Basal parasympathetic deficits in C9orf72 hexanucleotide repeat expansion carriers relate to smaller frontoinsula and thalamus volume and lower empathy
2024-01-011
OAAI
[18F]PI-2620 Binding Patterns in Patients with Suspected Alzheimer Disease and Frontotemporal Lobar Degeneration
2023-11-025
OA
Plasma inflammation for predicting phenotypic conversion and clinical progression of autosomal dominant frontotemporal lobar degeneration
2023-03-287
OAAI
Temporal order of clinical and biomarker changes in familial frontotemporal dementia

家族性额颞痴呆的临床和生物标志物变化的时间顺序

2022-09-2256
OA
Sensitivity of the Social Behavior Observer Checklist to Early Symptoms of Patients With Frontotemporal Dementia
2022-08-021
OA
Plasma Neurofilament Light for Prediction of Disease Progression in Familial Frontotemporal Lobar Degeneration

血浆神经丝光可预测家族性额颞叶变性的疾病进展

2021-05-0457
OAAI